Stroke Trial, Recruiting NCT06313866 Sponsor: Hangzhou Medical College Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06313866
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had a stroke (as defined by Traditional Chinese Medicine criteria), with symptoms such as weakness or paralysis on one side of the body, loss of sensation, difficulty speaking, or partial loss of vision
  • People who show significant problems in at least one area of thinking or memory, along with serious difficulty carrying out everyday tasks
  • People whose memory and thinking test scores fall below a certain level based on their education background (the trial site can clarify the specific score thresholds)
  • People aged under 70 years
  • People with no history of mental illness, who are fully conscious, have stable health signs, and are able to complete assessment questionnaires
  • People who are within 6 months of having a stroke and have been diagnosed as being in the recovery phase of a brain infarction or brain bleed
  • People who have signed an informed consent form, either themselves or through a family member

Who may not be able to join:

  • People who have had a transient ischemic attack (a brief, temporary stroke-like episode) rather than a full stroke
  • People who have had a subarachnoid hemorrhage (a specific type of bleeding around the brain)
  • People with a history of severe liver or kidney disease, mental illness, epilepsy, asthma, or chronic obstructive lung disease
  • People whose memory or thinking problems started before their stroke
  • People with severe difficulties in communication
  • People with a history of substance abuse or heavy alcohol use
  • People who have an implanted heart pacemaker or any other implanted electronic device

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Xinyun Li, doctor, hangzhou medical colleage

Phone: 8618069783240

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hangzhou Medical College
Registry
ClinicalTrials.gov
Start date
1 April 2024
Est. completion
1 April 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

MoCA

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov